Multidrug Efflux Pumps and Cancer Stem Cells: Insights Into Multidrug Resistance and Therapeutic Development

被引:234
作者
Moitra, K. [1 ]
Lou, H. [2 ]
Dean, M. [1 ]
机构
[1] NCI, Expt Immunol Lab, Human Genet Sect, Canc & Inflammat Program, Frederick, MD 21701 USA
[2] SAIC Frederick, Human Genet Sect, Basic Sci Program, Frederick, MD USA
基金
美国国家卫生研究院;
关键词
BINDING CASSETTE TRANSPORTER; SIDE POPULATION CELLS; ABCG2; EXPRESSION; DRUG-RESISTANCE; P-GLYCOPROTEIN; MESSENGER-RNA; MDR1; PROMOTER; UNTRANSLATED REGION; PROTEIN; GENE;
D O I
10.1038/clpt.2011.14
中图分类号
R9 [药学];
学科分类号
100702 [药剂学];
摘要
Stem cells possess the dual properties of self-renewal and pluripotency. Self-renewal affords these populations the luxury of self-propagation, whereas pluripotency allows them to produce the multitude of cell types found in the body. Protection of the stem cell population from damage or death is critical because these cells need to remain intact throughout the life of an organism. The principal mechanism of protection is through expression of multifunctional efflux transporters-the adenosine triphosphate-binding cassette (ABC) transporters that are the "guardians" of the stem cell population. Ironically, it has been shown that these ABC efflux pumps also afford protection to cancer stem cells (CSCs), shielding them from the adverse effects of chemotherapeutic insult. It is therefore imperative to gain a better understanding of the mechanisms involved in the resistance of stem cells to chemotherapy, which could lead to the discovery of new therapeutic targets and improvement of current anticancer strategies.
引用
收藏
页码:491 / 502
页数:12
相关论文
共 50 条
[1]
ABCG2 expression is correlated neither to side population nor to hematopoietic progenitor function in human umbilical cord blood [J].
Alt, Rudiger ;
Wilhelm, Franziska ;
Pelz-Ackermann, Oliver ;
Egger, Dietmar ;
Niederwieser, Dietger ;
Cross, Michael .
EXPERIMENTAL HEMATOLOGY, 2009, 37 (02) :294-301
[2]
Biochemical, cellular, and pharmacological aspects of the multidrug transporter [J].
Ambudkar, SV ;
Dey, S ;
Hrycyna, CA ;
Ramachandra, M ;
Pastan, I ;
Gottesman, MM .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1999, 39 :361-398
[3]
Promoter characterization and genomic organization of the human breast cancer resistance protein (ATP-binding cassette transporter G2) gene [J].
Bailey-Dell, KJ ;
Hassel, B ;
Doyle, LA ;
Ross, DD .
BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION, 2001, 1520 (03) :234-241
[4]
MODULATION OF ACTIVITY OF THE PROMOTER OF THE HUMAN MDR1 GENE BY RAS AND P53 [J].
CHIN, KV ;
UEDA, K ;
PASTAN, I ;
GOTTESMAN, MM .
SCIENCE, 1992, 255 (5043) :459-462
[5]
CORNWELL MM, 1990, CELL GROWTH DIFFER, V1, P607
[6]
CORNWELL MM, 1993, J BIOL CHEM, V268, P19505
[7]
Tumour stem cells and drug resistance [J].
Dean, M ;
Fojo, T ;
Bates, S .
NATURE REVIEWS CANCER, 2005, 5 (04) :275-284
[8]
Dean M., 2002, HUMAN ATP BINDING CA
[9]
MicroRNA Regulation of Cancer Stem Cells and Therapeutic Implications [J].
DeSano, Jeffrey T. ;
Xu, Liang .
AAPS JOURNAL, 2009, 11 (04) :682-692
[10]
Identification of a novel estrogen response element in the breast cancer resistance protein (ABCG2) gene [J].
Ee, PLR ;
Kamalakaran, S ;
Tonetti, D ;
He, XL ;
Ross, DD ;
Beck, WT .
CANCER RESEARCH, 2004, 64 (04) :1247-1251